About the authors
Delia Bishara is a consultant pharmacist, Mental Health of Older Adults (MHOA) and Dementia, SLaM, London, UK. Charlotte Scott is a speciality registrar at SLaM, London, UK. Robert Stewart is Professor of Psychiatric Epidemiology & Clinical Informatics at the Biomedical Research Centre, SLaM and King's College London, UK. David Taylor is Director of Pharmacy and Pathology and Head of the Pharmaceutical Sciences Clinical Academic Group, King's Health Partners, SLaM, London, UK. Daniel Harwood is a consultant psychiatrist and Clinical Director of MHOA and Dementia Clinical Academic Group, SLaM, London, UK. David Codling is a senior registrar at SLaM, London, UK. Christine Banwell is a pharmacist at SLaM, London, UK. Justin Sauer is a consultant psychiatrist and Clinical Lead for Memory Services at SLaM, London, UK.
1Carriere, I, Fourrier-Reglat, A, Dartigues, JF, Rouaud, O, Pasquier, F, Ritchie, K, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 2009; 169: 1317–24.
2Jessen, F, Kaduszkiewicz, H, Daerr, M, Bickel, H, Pentzek, M, Riedel-Heller, S, et al. Anticholinergic drug use and risk for dementia: target for dementia prevention. Eur Arch Psychiatry Clin Neurosci 2010; 260(Suppl 2): S111–5.
3Fox, C, Richardson, K, Maidment, ID, Savva, GM, Matthews, FE, Smithard, D, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc 2011; 59: 1477–83.
4Gray, SL, Anderson, ML, Dublin, S, Hanlon, JT, Hubbard, R, Walker, R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Internal Med 2015; 175: 401–7.
5Lu, CJ, Tune, LE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry 2003; 11: 458–61.
6Sink, KM, Thomas, J III, Xu, H, Craig, B, Kritchevsky, S, Sands, LP. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc 2008; 56: 847–53.
9Boustani, M, Campbell, N, Munger, S, Maidment, I, Fox, C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 2008; 4: 311–20.
10Duran, CE, Azermai, M, Vander Stichele, RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol 2013; 69: 1485–96.
11Bishara, D, Harwood, D, Sauer, J, Taylor, D. Anticholinergic effect on cognition (AEC) of drugs commonly used in older people. Int J Geriatr Psychiatry 2017; 32(6): 650–6.